Allianz’s Astera Labs ALAB Stock Holding History

Allianz’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$42K	Hold	87	–	–	﹤0.01%	442
2026 Q1	$9.54K	Buy	+87	New	+$12.4K	﹤0.01%	446

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Allianz's ALAB Position: Q2 2026 in Review

Allianz held its Astera Labs (ALAB) position steady in Q2 2026 at 87 shares worth $42K. The position accounts for ﹤0.01% of the portfolio, ranked #442.

Allianz first reported a position in ALAB in Q1 2026 and has held it in 2 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

Allianz held 87 shares of Astera Labs worth $42K as of Q2 2026.
Allianz left its Astera Labs share count unchanged in Q2 2026.
Astera Labs made up ﹤0.01% of Allianz's portfolio in Q2 2026, its #442 holding.
Allianz first reported a position in Astera Labs in Q1 2026 and has held it in 2 quarters since.
988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Allianz's 13F filing for Q2 2026, filed 10 Aug 2026.